Janney Capital Management »

Ligand Pharmaceuticals In shares owned by Janney Capital Management

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Janney Capital Management from 13F filings

Historical chart of Janney Capital Management investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Janney Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Janney Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $456k 4.6k 100.00
2024-06-30 $491k 5.8k 84.18
2018-09-30 $8.2M 30k 274.49

More positions owned by Janney Capital Management

Microsoft Corp Common Stock (MSFT)
Tech Sel Sect Spdr Etf ETF/Closed End (XLK)
Taiwan Semicon Mfg Common Stock (TSM)
Select Commn Svc Sel Etf ETF/Closed End (XLC)
Spdr Dbllin T/r Tact Etf ETF/Closed End- (TOTL)
Broadcom Common Stock (AVGO)
Jpmorgan Chase Common Stock (JPM)
Ishs Russ 2000 Indx Etf ETF/Closed End (IWM)
Intl Business Machs Corp Common Stock (IBM)
Spdr Gold Trust Gold Etf Alternatives - (GLD)
Abbvie Common Stock (ABBV)
Mcdonalds Corp Common Stock (MCD)
Utils Sel Sect Spdr Etf ETF/Closed End (XLU)
Sel Sect Rl Est Spdr Etf ETF/Closed End (XLRE)
Spdr Sp Bank Etf ETF/Closed End (KBE)

View all positions for Janney Capital Management

Top funds holding Ligand Pharmaceuticals In

BlackRock
BlackRock
Vanguard Group
Henderson Group
Macquarie Group
Dimensional Fund Advisors
State Street Corporation
Stephens Investment Management Group
Congress Asset Management
Chicago Capital
St. Denis J. Villere & Co
Geode Capital Management
Rice Hall James & Associates
Ashford Capital Management
Impax Asset Management Group

View all funds holding Ligand Pharmaceuticals In